Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.
After several challenging quarters, Regeneron's sales growth is rebounding. In the first quarter, the company's revenue rose ...
By Prakhar Srivastava May 8 (Reuters) - Odyssey Therapeutics secured a valuation of $899.9 million after its shares rose 11.1% in their Nasdaq debut on Friday, signaling solid investor demand for ...
May 8 () - Odyssey Therapeutics shares rose 11.1% in its Nasdaq debut on Friday, giving the biopharmaceutical firm a valuation of $899.
Smaller biotech stocks often fly under the radar. Many of them aren't consistently profitable, but some can deliver outsize ...
The biotech group has struggled as a whole in 2025, but analysts say the innovation that has always supported the biotech ...
Corcept Therapeutics Inc. (NASDAQ: CORT) is one of the 10 best biotech stocks with highest upside potential.
On April 20, Pinnacle Food Group Limited (NASDAQ:PFAI) announced that its subsidiary has signed a non-binding memorandum of ...
Investor's Business Daily on MSN
Why this biotech ETF — the IBD stock of the day — just reentered its buy zone
The SPDR S&P Biotech ETF, often referred to simply as the XBI, is Monday's IBD Stock Of The Day. Shares just reentered a buy ...
In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector’s two major indexes — the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) — ...
Krystal Biotech delivered strong Q1 2026 results, with Vyjuvek sales up 32% YoY to $116.4M and gross margin expanding to 95%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results